Satoyasu Ito
Kobe, 6508530, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
β-Hydroxybutyrate Attenuates Cardiac Inflammation and Hepatic Fibrosis in Dahl Salt-Sensitive Rats.
Journal: Current issues in molecular biology
Published: May 15, 2026
Dimethyl Fumarate Ameliorated Cardiorenal Anemia Syndrome and Improved Overall Survival in Dahl/Salt-Sensitive Rats.
Journal: The Journal of pharmacology and experimental therapeutics
Published: April 18, 2023
Juzentaihoto improves adenine-induced chronic renal failure in BALB/c mice via suppression of renal fibrosis and inflammation.
Journal: Journal of pharmacological sciences
Published: March 27, 2021
Low Quality of Warfarin Therapy is Associated With Female Gender but Not With Polypharmacy in Patients With Atrial Fibrillation.
Journal: Frontiers in pharmacology
Published: January 13, 2021
Polypharmacy Is Associated With Accelerated Deterioration of Renal Function in Cardiovascular Outpatients.
Journal: Cardiology research
Published: November 22, 2019
Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways.
Journal: PloS one
Published: March 23, 2015
Olmesartan inhibits cultured rat aortic smooth muscle cell death induced by cyclic mechanical stretch through the inhibition of the c-Jun N-terminal kinase and p38 signaling pathways.
Journal: Journal of pharmacological sciences
Published: September 01, 2014
Intermittent hypoxia induces the proliferation of rat vascular smooth muscle cell with the increases in epidermal growth factor family and erbB2 receptor.
Journal: Experimental cell research
Published: April 11, 2013
Role of big mitogen-activated protein kinase 1 (BMK1) / extracellular signal-regulated kinase 5 (ERK5) in the pathogenesis and progression of atherosclerosis.
Journal: Journal of pharmacological sciences
Published: November 21, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026